Revelation Biosciences, Inc. (REVB) stock
REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
$3.88+0.06 (+1.57%)
Close on Nov 17, 2026Market cap $15.46MP/E –Yield –
Revelation Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Revelation Biosciences's price to book ratio was 1.7× on Nov 11, 2026, against 8.7× a year earlier. Over the last 2 years it ranged from 0.2× to 447.1×, with a median of 7.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | −5.6 |
| 2025 | Dec 31, 2025 | 7.3× | −375.0 |
| 2024 | Jul 31, 2024 | 382.3× | – |
See a number that looks wrong?